Infinity Historical Financial Ratios

Infinity Pharmaceuticals is lately reporting on over 80 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 0.0 or Invested Capital of 0.0 will help investors to properly organize and evaluate Infinity Pharmaceuticals financial condition quickly.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Infinity Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Infinity Stock, please use our How to Invest in Infinity Pharmaceuticals guide.

About Infinity Financial Ratios Analysis

Infinity PharmaceuticalsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Infinity Pharmaceuticals investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Infinity financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Infinity Pharmaceuticals history.

Infinity Pharmaceuticals Financial Ratios Chart

At this time, Infinity Pharmaceuticals' Sales General And Administrative To Revenue is relatively stable compared to the past year. As of 03/30/2025, Cash Per Share is likely to grow to 0.74, though Book Value Per Share is likely to grow to (0.23).
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AShort Term Coverage Ratios
Price Earnings RatioOperating Cycle
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Infinity Pharmaceuticals stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Infinity Pharmaceuticals sales, a figure that is much harder to manipulate than other Infinity Pharmaceuticals multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.
Most ratios from Infinity Pharmaceuticals' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Infinity Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Infinity Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Infinity Stock, please use our How to Invest in Infinity Pharmaceuticals guide.At this time, Infinity Pharmaceuticals' Sales General And Administrative To Revenue is relatively stable compared to the past year. As of 03/30/2025, Cash Per Share is likely to grow to 0.74, though Book Value Per Share is likely to grow to (0.23).
 2021 2022 2024 2025 (projected)
Current Ratio6.192.963.44.68
Net Debt To EBITDA1.780.860.770.64

Infinity Pharmaceuticals fundamentals Correlations

-0.05-0.040.940.34-0.48-0.050.940.360.450.29-0.47-0.470.28-1.0-0.190.47-1.00.440.10.26-0.9-1.00.72-0.910.95
-0.051.00.1-0.750.821.0-0.1-0.760.84-0.750.820.810.810.040.61-0.810.07-0.850.1-0.93-0.010.070.460.010.07
-0.041.00.09-0.690.771.0-0.11-0.710.84-0.70.780.770.810.020.55-0.770.05-0.820.1-0.90.010.050.50.030.07
0.940.10.090.04-0.230.10.960.070.610.0-0.22-0.220.32-0.930.130.22-0.920.250.260.03-0.97-0.910.6-0.971.0
0.34-0.75-0.690.04-0.96-0.750.161.0-0.551.0-0.96-0.97-0.49-0.33-0.960.97-0.350.9-0.090.93-0.01-0.370.15-0.030.08
-0.480.820.77-0.23-0.960.82-0.35-0.970.51-0.961.01.00.520.460.86-1.00.48-0.970.04-0.970.220.5-0.110.24-0.27
-0.051.01.00.1-0.750.82-0.1-0.760.84-0.750.820.810.810.040.61-0.810.07-0.850.1-0.93-0.010.070.460.010.07
0.94-0.1-0.110.960.16-0.35-0.10.180.410.11-0.35-0.350.24-0.940.040.35-0.940.360.070.19-0.99-0.930.52-0.990.96
0.36-0.76-0.710.071.0-0.97-0.760.18-0.551.0-0.97-0.98-0.5-0.34-0.950.97-0.370.91-0.080.94-0.04-0.390.14-0.060.11
0.450.840.840.61-0.550.510.840.41-0.55-0.580.520.510.74-0.440.53-0.51-0.42-0.50.34-0.7-0.49-0.410.67-0.470.58
0.29-0.75-0.70.01.0-0.96-0.750.111.0-0.58-0.95-0.96-0.52-0.28-0.970.96-0.310.89-0.090.930.04-0.320.110.010.04
-0.470.820.78-0.22-0.961.00.82-0.35-0.970.52-0.951.00.530.450.86-1.00.48-0.970.03-0.970.210.49-0.090.24-0.26
-0.470.810.77-0.22-0.971.00.81-0.35-0.980.51-0.961.00.520.450.87-1.00.48-0.960.04-0.970.210.49-0.110.23-0.26
0.280.810.810.32-0.490.520.810.24-0.50.74-0.520.530.52-0.330.41-0.52-0.3-0.67-0.37-0.69-0.31-0.30.67-0.290.29
-1.00.040.02-0.93-0.330.460.04-0.94-0.34-0.44-0.280.450.45-0.330.18-0.461.0-0.41-0.03-0.240.91.0-0.730.91-0.94
-0.190.610.550.13-0.960.860.610.04-0.950.53-0.970.860.870.410.18-0.870.21-0.770.14-0.83-0.190.23-0.19-0.170.09
0.47-0.81-0.770.220.97-1.0-0.810.350.97-0.510.96-1.0-1.0-0.52-0.46-0.87-0.480.97-0.040.97-0.21-0.490.11-0.240.26
-1.00.070.05-0.92-0.350.480.07-0.94-0.37-0.42-0.310.480.48-0.31.00.21-0.48-0.44-0.03-0.270.91.0-0.730.9-0.93
0.44-0.85-0.820.250.9-0.97-0.850.360.91-0.50.89-0.97-0.96-0.67-0.41-0.770.97-0.440.180.96-0.24-0.45-0.01-0.260.29
0.10.10.10.26-0.090.040.10.07-0.080.34-0.090.030.04-0.37-0.030.14-0.04-0.030.18-0.06-0.09-0.02-0.03-0.080.27
0.26-0.93-0.90.030.93-0.97-0.930.190.94-0.70.93-0.97-0.97-0.69-0.24-0.830.97-0.270.96-0.06-0.06-0.28-0.15-0.080.07
-0.9-0.010.01-0.97-0.010.22-0.01-0.99-0.04-0.490.040.210.21-0.310.9-0.19-0.210.9-0.24-0.09-0.060.89-0.491.0-0.96
-1.00.070.05-0.91-0.370.50.07-0.93-0.39-0.41-0.320.490.49-0.31.00.23-0.491.0-0.45-0.02-0.280.89-0.730.89-0.92
0.720.460.50.60.15-0.110.460.520.140.670.11-0.09-0.110.67-0.73-0.190.11-0.73-0.01-0.03-0.15-0.49-0.73-0.490.61
-0.910.010.03-0.97-0.030.240.01-0.99-0.06-0.470.010.240.23-0.290.91-0.17-0.240.9-0.26-0.08-0.081.00.89-0.49-0.96
0.950.070.071.00.08-0.270.070.960.110.580.04-0.26-0.260.29-0.940.090.26-0.930.290.270.07-0.96-0.920.61-0.96
Click cells to compare fundamentals

Infinity Pharmaceuticals Account Relationship Matchups

Pair Trading with Infinity Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Infinity Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Infinity Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Infinity Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Infinity Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Infinity Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Infinity Pharmaceuticals to buy it.
The correlation of Infinity Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Infinity Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Infinity Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Infinity Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Infinity Stock Analysis

When running Infinity Pharmaceuticals' price analysis, check to measure Infinity Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuticals is operating at the current time. Most of Infinity Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infinity Pharmaceuticals' price. Additionally, you may evaluate how the addition of Infinity Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.